Closed · HR001123S0037 · CFDA 12.910 · Discretionary

Synthetic Hemo-technologIEs to Locate and Disinfect (SHIELD)

Federal grant opportunity posted by DARPA - Biological Technologies Office, cataloged on Grants.gov.

Varies
Award range
Closed
Status
September 27, 2023
Close date
-
Expected awards

The verdict

Synthetic Hemo-technologIEs to Locate and Disinfect (SHIELD) is a closed discretionary listing from DARPA - Biological Technologies Office that offered Varies by applicant. Future funding cycles may be published under the same CFDA number.

Varies
award range
Closed
application status
12.910
CFDA program

Opportunity snapshot. This Grants.gov announcement - Synthetic Hemo-technologIEs to Locate and Disinfect (SHIELD) - is cataloged under number HR001123S0037 and tied to CFDA assistance listing 12.910, posted by DARPA - Biological Technologies Office. Grants.gov currently shows the opportunity as closed, first posted on June 28, 2023 and last updated on July 25, 2023. The funding category is Discretionary, delivered as a procurement contract.

Award economics. The award range on file is Varies by applicant. Cost sharing is not required, so applicants do not need to commit matching funds to be competitive on this opportunity. Federal award ranges are often upper bounds; actual allocations reflect program appropriations, the strength of the applicant pool, and the evaluation committee's scoring.

Deadline and action path. This opportunity closed on September 27, 2023. Future funding cycles may be published under the same CFDA number, so monitoring the parent program page is the most reliable way to catch re-announcements. Every Grants.gov submission requires an active SAM.gov registration and a Unique Entity ID. Review the Eligibility section below carefully, federal eligibility categories (nonprofit, state or local government, tribal, individual, educational institution, small business) have distinct registration and reporting requirements. Pre-application outreach to the listed agency contact is permitted and often welcomed, it helps clarify scope and scoring priorities. Before acting on the deadline or award figures above, verify them directly on the official Grants.gov listing, amendments can change dates and amounts after this page was last refreshed.

Award Range

Varies by applicant

Close Date

September 27, 2023

See Full Announcement for details.

Posted

June 28, 2023

Instrument

Procurement Contract

Description

The Synthetic Hemo-technologIEs to Locate and Disinfect (SHIELD) program will develop safe and effective prophylactic countermeasures to defeat bloodborne pathogens and prevent bloodstream infections (BSI) associated with combat wounds. The program will develop prophylactic countermeasures effective against both bacteria and fungi, pathogens that are responsible for the vast majority of BSI. State-of-the-art countermeasures to manage BSI include antifungals and antibiotics which can be toxic, ineffective, and be administered in an untimely manner. SHIELD will develop safe and effective broad-spectrum prophylaxes that will protect recipients from bloodborne bacteria and fungi and prevent BSI for up to 144 h.

Eligibility

Grants.gov lists this opportunity under eligibility category code 25. These codes correspond to applicant types (state/local government, tribal organization, nonprofit, educational institution, individual, small business, etc.) defined in Grants.gov's own eligibility reference. See the current Grants.gov eligibility categories or check the official listing below for this opportunity's exact eligibility statement.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

BAA Coordinator SHIELD@darpa.mil

Key Dates

Posted June 28, 2023
Close Date September 27, 2023
Archive Date October 27, 2023
Last Updated July 25, 2023

Frequently Asked Questions

What is this grant opportunity?
This is a federal funding opportunity titled "Synthetic Hemo-technologIEs to Locate and Disinfect (SHIELD)", offered by DARPA - Biological Technologies Office. It is associated with CFDA program 12.910. The Synthetic Hemo-technologIEs to Locate and Disinfect (SHIELD) program will develop safe and effective prophylactic countermeasures to defeat bloodborne pathogens and prevent bloodstream infections ...
Is this opportunity still open?
No, this opportunity is closed. It closed on September 27, 2023. Check the parent program page for future funding cycles.
How much funding is available?
The award range for this opportunity is Varies by applicant.
How do I apply?
Applications for federal grant opportunities are typically submitted through Grants.gov. Visit the official listing at grants.gov for application instructions, required documents, and submission deadlines.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants